Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00363_DB00730_nanopub.RA5k3dKKOrk2jfGbW3to0vDxO8_wt-TsDmLoSms9XXWHE#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00363_DB00730 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00363_DB00730 label "DDI between Clozapine and Thiabendazole - The strong CYP1A2 inhibitor, Thiabendazole, may increase the effects and toxicity of Clozapine by decreasing Clozapine metabolism and clearance. Monitor for changes in the therapeutic and adverse effects of Clozapine if Thiabendazole is initiated, discontinued or dose changed. [drugbank_resource:DB00363_DB00730]" assertion.
- drugbank_resource:DB00363_DB00730 identifier "drugbank_resource:DB00363_DB00730" assertion.
- drugbank_resource:DB00363_DB00730 title "DDI between Clozapine and Thiabendazole - The strong CYP1A2 inhibitor, Thiabendazole, may increase the effects and toxicity of Clozapine by decreasing Clozapine metabolism and clearance. Monitor for changes in the therapeutic and adverse effects of Clozapine if Thiabendazole is initiated, discontinued or dose changed." assertion.
- drugbank:DB00363 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00363_DB00730 assertion.
- drugbank:DB00730 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00363_DB00730 assertion.